Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disordersTranexamic acid for preventing postpartum haemorrhageAntifibrinolytic drugs for acute traumatic injuryAntifibrinolytic therapy to reduce haemoptysis from any causeAntifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersAnti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersCRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social MediaThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionApplying results from clinical trials: tranexamic acid in trauma patientsAntifibrinolytic therapy to reduce haemoptysis from any cause.Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series.Tranexamic acid in pediatric trauma: why not?Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial.Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.Tranexamic acid for traumatic brain injury: a systematic review and meta-analysisInvestigational agents for treatment of traumatic brain injuryClinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.The utility of recombinant factor VIIa as a last resort in trauma.CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trialPharmacological adjuncts to stop bleeding: options and effectiveness.John Snow's legacy: epidemiology without bordersA Systematic Review of the State of Economic Evaluation for Health Care in India.Paediatric trauma resuscitation: an update.USE OF TRANEXAMIC ACID IN TRAUMA PATIENTS: AN ANALYSIS OF COST-EFFECTIVENESS FOR USE IN BRAZIL.A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery.The truth about road traffic accidents.Tranexamic Acid: a recipe for saving lives in traumatic bleeding.Tranexamic Acid - a recipe for saving lives in traumatic bleeding.Tranexamic acid for postpartum bleeding.The role of tranexamic acid in prevention of hemorrhage in major spinal surgeries.Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1).Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery-A Pilot Study.From point of wounding: damage control resuscitation.Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion.Development of a Prehospital Tranexamic Acid Administration Protocol.Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.Damage Control Resuscitation.Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.
P2860
Q21092902-C9018679-ADB8-4461-B3F5-D797F86E4F32Q24186028-25B70704-0CD5-4FDA-8643-A2213922E715Q24187146-29CDFE2D-7F30-4B25-A25E-8E0040A42317Q24188000-499DEBCD-DB92-426D-8813-2401E00AFF98Q24200405-AABFCB3D-BB1B-477E-B298-A9DB7997A678Q24201018-273C5E42-0EDF-477A-83A8-3DC0F526AAA6Q24201514-9A97784B-E5C2-409D-99F5-0C5134D521F5Q26785966-D9B39D28-7D7D-4A6E-A1F2-CBB3B292F161Q27339343-A3811092-DAF4-474E-989C-3C5DF7A5C7DFQ28082587-1A9CCC96-4899-496D-B801-2429B8823738Q30241963-6BF786D6-EDD6-406D-A863-700D069B909AQ33420118-260EB495-7FAC-4F7E-8369-56D3B2C6B7C6Q33892479-10C81327-92A5-4252-8C0B-500508414359Q34180460-319E13E9-5C9C-4014-A877-4D56C3EBF4B0Q34422906-017429C2-9D49-4F32-A96A-4F57836A2807Q34620403-23CC36DA-CF28-4A9D-9249-F8939B9DCB48Q35466780-BE3C934A-8358-4AF8-BF99-923F69FF68DFQ35611476-4225ECC6-2F67-4A28-93A4-9E17632D3B22Q36073080-70EBBFF3-4E06-4C65-8595-FB6D0CA0C9C3Q36181277-0B0CEF4B-03E5-4158-A7E7-19E7442386EFQ36347953-CD845646-5C14-4E29-85E6-B0F035773A4FQ36949376-6BAE66A9-9EC8-4A72-81A5-60B58EDEFEE3Q37061629-200C8F6F-862C-42F5-B805-69DF67E802ABQ38602629-A79ED00F-8776-4781-92E7-647609D7B294Q38676780-6A2A217D-C6FD-45AB-8161-5E723F50F3DEQ39027030-A0457323-347D-42C0-A44E-2213BB5A4FB7Q39202981-9B41D39D-A71E-44F0-BC5C-3B5A11657FA8Q39401841-B1E73161-E8DA-4C4F-847B-E40E09C46926Q39401848-C9F92F14-5567-4CFF-A8AD-5E7076BC29F1Q39401870-8DDAC641-137A-4225-91D4-82C78F2D9BFFQ39401903-9FE797E6-7CC6-4923-AAB5-CCA9B9AF9AA3Q41165267-0566EC0A-7F0F-4FF5-95D9-39AFE17C4E3DQ42650009-2F4CB423-94AE-46C4-9513-3470A4D0FCA7Q42718785-9B931728-5A80-4CFF-BD96-B01116870735Q45009704-BB4BA58F-7886-4F93-86FC-D777C83D1215Q46439266-A3B2F55A-3EF0-4C6C-897E-5358DA9BE247Q47714922-50401D9A-68FD-4E83-A315-C8DBA576BBDCQ49373622-E4C7014F-CF54-404C-9422-452ABF5412B5Q50457260-B25FC4DC-61B1-43F8-8D3D-8BC33FFC9E32Q50473233-EB314DE5-34BD-4C66-A076-063A36E00374
P2860
Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@ast
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en-gb
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@nl
type
label
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@ast
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en-gb
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@nl
altLabel
Cost-Effectiveness Analysis of ...... vidence from the CRASH-2 Trial
@en
prefLabel
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@ast
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en-gb
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@nl
P2093
P2860
P3181
P1433
P1476
Cost-effectiveness analysis of ...... vidence from the CRASH-2 trial
@en
P2093
Carla Guerriero
Ian Roberts
Pablo Perel
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0018987
P407
P577
2011-01-01T00:00:00Z